Yuji Otsuki
Chief Executive Officer FerroptoCure
Graduated from the Faculty of Medicine, Hokkaido University, and completed his doctorate in medicine at Keio University. He is currently engaged in research and development as the leader of our company’s anticancer drug development. He also has experience in managing a clinic. Currently the project leader at Keio University and Fujita Health University.
Seminars
Tuesday 19th May 2026
Biomarker Strategy in the Clinical Development of Ferroptosis-Based Cancer Therapy
12:00 pm
- Overview of FerroptoCure’s biomarker strategy to support the clinical development of ferroptosis-based cancer therapies
- Current progress and future direction in identifying biomarkers for pharmacodynamic response and clinical utility in refractory cancers such as TNBC
